Archive for the ‘Chief executive officer’ Category

Emergent BioSolutions Awarded HHS Contract Valued at Up to $107 Million to Develop Large-Scale Manufacturing for BioThrax

ROCKVILLE, Md., Jul 14, 2010
Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has signed a contract valued at up to $107 million with the Office of the Biomedical Advanced Research and Development Authority (BARDA) of the Department of Health and Human Services (HHS), to develop and obtain regulatory approval for large-scale [...]

July 15, 2010  Tags: , , , , ,   Posted in: Chief executive officer, Emergent BioSolutions, U.S. Food and Drug Administration, United States, fuad el-hibri  No Comments

The El-Hibri Foundation Launches Website

The El-Hibri Foundation is a nonprofit organization with the goal of fostering dialogue between various religions and encouraging nonviolent solutions to global challenges affecting humankind.  The Foundation has a new website at www.elhibrifoundation.org.
The Foundation, lead by Chairman of the Board of Trustees Fuad El-HIbri, is divided into [...]

July 14, 2010  Tags: , , , ,   Posted in: Chief executive officer, El-Hibri Peace Education Prize, Foundation, fuad el-hibri  No Comments

Emergent BioSolutions Hosts Biopreparedness Roundtable for NATO Parliamentarians

ROCKVILLE, Md., Jul 12, 2010 (BUSINESS WIRE) –
Emergent BioSolutions Inc. (NYSE:EBS) is hosting “Bioterrorism Prevention, Preparedness and Response,” a forum organized for members of the North Atlantic Treaty Organization (NATO) Parliamentary Assembly (PA) to raise global awareness of the importance of biopreparedness. The visiting delegation [...]

July 13, 2010  Tags: , , , , ,   Posted in: Chief executive officer, Emergent BioSolutions, NATO, United States, United States Department of Health and Human Services, fuad el-hibri  No Comments

Emergent BioSolutions Completes Deliveries of BioThrax to Allied Foreign Governments

ROCKVILLE, MD, June 24, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) led by CEO Fuad El-Hibri,announced today that it has completed separate international sales and deliveries of BioThrax® (Anthrax Vaccine Adsorbed) to governments of several allied nations.  The company’s international sales efforts have resulted in these sales [...]

July 7, 2010  Tags: , , , , , ,   Posted in: Anthrax vaccines, Chief executive officer, Emergent BioSolutions, Halth Care, fuad el-hibri  No Comments

Emergent BioSolutions to Participate in June 2010 Investor Conferences

Fuad El-Hibri, CEO of Emergent BioSolutions Inc., announces that the company will be participating in the following investor conferences during June 2010:

The Jefferies & Company 2010 Global Life Sciences Conference
New [...]

June 7, 2010  Tags: , , , , , ,   Posted in: Business, Chief executive officer, Emergent BioSolutions, Healthcare Conference, fuad el-hibri  No Comments

Emergent BioSolutions Recognized as Biotechnology Firm of the Year by Tech Council of Maryland

ROCKVILLE, MD, May 13, 2010 – Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has been named Biotechnology Firm of the Year at the Tech Council of Maryland’s (TCM) Annual Tech Awards.  This award acknowledges the company that best exemplifies the spirit of Maryland’s biotechnology community as well as its presence and leadership within the [...]

May 18, 2010  Tags: , , , , , ,   Posted in: Chief executive officer, Emergent BioSolutions, Management, Tech Council of Maryland, U.S. Food and Drug Administration, fuad el-hibri  No Comments

Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary Assembly

Emergent BioSolutions’ senior management team, headed by Fuad El-Hibri, chairman and chief executive officer and Daniel J. Abdun-Nabi, president and chief operating officer, are hosting “Bioterrorism Prevention, Preparedness and Response,” a forum uniquely organized for members of the North Atlantic Treaty Organization (NATO) Parliamentary Assembly (PA). The one-day event is an interactive discussion related to [...]

May 11, 2010  Tags: , , , , , , ,   Posted in: Chief executive officer, Emergent BioSolutions, Hudson Institute, North Atlantic Treaty Organization, United States Department of Defense, fuad el-hibri  No Comments

Emergent BioSolutions Chairman and CEO Fuad El-Hibri Recognized as Outstanding International Business Leader

ROCKVILLE, Md., Mar 11, 2010 (BUSINESS WIRE) — Emergent BioSolutions Inc. (EBS 15.96, -0.03, -0.19%) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been named by the World Trade Center Institute (WTCI) as one of Maryland’s outstanding international business leaders. Celebrating the spirit of global ambition and excellence in international leadership, [...]

March 15, 2010  Tags: , , , , ,   Posted in: Chief executive officer, El-Hibri, Emergent BioSolutions, Maryland, United States, fuad el-hibri  No Comments

500 Most Influential Muslims: Science and Technology

The Prince Alwaleed Bin Talaal Center for Muslim-Christian Understanding and The Royal Islamic Strategic Studies Centre published its first edition in what promises to be an annual series of insight into the movers and shakers of the Muslim world. Entitled The 500 Most Influential Muslims 2009, the book categorizes Muslims’ influential capacities into 15 [...]

January 6, 2010  Tags: , , , ,   Posted in: Chief executive officer, Chief operating officer, Emergent BioSolutions, Social Network, U.S. Food and Drug Administration, Washington, fuad el-hibri  No Comments

Fuad el-Hibri, king of anthrax, wins an award from Ernst & Young

Marie-José Daoud
Awarded the Ernst and Young prize for Entrepreneur of the year 2009 in the Technology category for the Greater Washington region last June, Fuad El-Hibri is the CEO of Emergent Biosolutions, an American company that supplies the anthrax vaccine to the American government. He is in line for the national E&Y 2009 prize, which [...]

December 17, 2009  Tags: , , , ,   Posted in: Chief executive officer, Emergent BioSolutions, Management, Maryland, U.S. Food and Drug Administration, Washington, fuad el-hibri  No Comments